KAIST

KAIST will make the antivirus industry the centerpiece of what it is touting as the KAIST New Deal R&D initiative, which will drive new growth engines for preparing for the post-coronavirus era.

According to the new initiative, KAIST will concentrate on creating antivirus technologies, infectious disease-related big data management, and non-contact services platforms as key future R&D projects.

President Sung-Chul Shin launched the COVID-19 R&D Initiative task force last month, composed of more than 50 professors from the Graduate School of Medical Science and Engineering, the Department of Biological Sciences, the College of Engineering, and the Department of Industrial Design. The task force came up with key research agendas that will promote smart mobile medical systems in the years ahead.

“We will devote all of our R&D capacities to pursue a smart healthcare society,” said President Shin. “Our competitiveness in the fields of AI, ICT, materials, and bio-technology holds significant potential for building a healthy society powered by smart medical systems in Korea,” he added.

Click here to read a related article.

(END)